NADAC acquisition cost data for METHENAMINE MAND 1 GM TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| Generic Name | Methenamine Mandelate |
| Manufacturer | Chattem Chemicals, Inc. |
| Dosage Form | POWDER |
| Product Type | BULK INGREDIENT |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 13925010701 | $1.74 | 2021-06-23 | Rx |
| 42799010601 | $1.74 | 2021-06-23 | Rx |
| 13925010701 | $1.74 | 2021-06-23 | Rx |
| 42799010601 | $1.74 | 2021-06-23 | Rx |
| 13925010701 | $1.74 | 2021-06-23 | Rx |
| 42799010601 | $1.74 | 2021-06-23 | Rx |
| 13925010701 | $1.74 | 2021-06-23 | Rx |
| 42799010601 | $1.74 | 2021-06-23 | Rx |
| 13925010701 | $1.74 | 2021-06-23 | Rx |
| 42799010601 | $1.74 | 2021-06-23 | Rx |
Generic: Methenamine Mandelate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $624.9K | 6,677 | 2,011 | $1.23 |
| 2020 | $996.6K | 9,907 | 2,778 | $1.26 |
| 2021 | $818.9K | 8,147 | 2,247 | $1.25 |
| 2022 | $784.3K | 7,917 | 2,245 | $1.23 |
| 2023 | $786.2K | 9,110 | 2,481 | $1.17 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $96.3K | 1,020 | 302 |
| Pennsylvania | $81.7K | 1,022 | 215 |
| New York | $71.1K | 779 | 205 |
| Florida | $64.2K | 759 | 261 |
| Texas | $38.3K | 462 | 160 |
| Georgia | $34.0K | 480 | 110 |
| Ohio | $28.7K | 319 | 98 |
| Massachusetts | $24.9K | 278 | 79 |
| Maryland | $24.4K | 244 | 75 |
| New Jersey | $22.3K | 185 | 70 |
| Virginia | $21.3K | 225 | 52 |
| Illinois | $21.3K | 258 | 69 |
| Wisconsin | $19.4K | 246 | 53 |
| Connecticut | $19.1K | 218 | 56 |
| North Carolina | $15.6K | 212 | 44 |
| Kentucky | $13.7K | 160 | 47 |
| Missouri | $12.8K | 159 | 44 |
| Minnesota | $12.4K | 166 | 28 |
| South Carolina | $12.2K | 124 | 36 |
| Iowa | $12.0K | 110 | 24 |
| Michigan | $11.6K | 125 | 52 |
| Arizona | $11.2K | 117 | 31 |
| Oklahoma | $10.5K | 104 | 34 |
| Colorado | $9.1K | 104 | 32 |
| Louisiana | $9.1K | 134 | 33 |
| Utah | $8.1K | 69 | 19 |
| Kansas | $6.9K | 114 | 29 |
| West Virginia | $6.7K | 73 | 24 |
| Oregon | $6.6K | 54 | 14 |
| Tennessee | $5.4K | 113 | 34 |
| Arkansas | $5.3K | 54 | 16 |
| Indiana | $4.8K | 87 | 24 |
| Mississippi | $4.7K | 60 | 17 |
| Alabama | $4.5K | 67 | 14 |
| Idaho | $4.5K | 42 | N/A |
| Nevada | $4.4K | 44 | 16 |
| New Mexico | $4.2K | 36 | 13 |
| Nebraska | $3.4K | 69 | 15 |
| Wyoming | $2.8K | 32 | N/A |
| Washington | $2.5K | 45 | 15 |
| Maine | $2.4K | 34 | N/A |
| Vermont | $2.3K | 14 | N/A |
| South Dakota | $1.9K | 29 | N/A |
| Rhode Island | $1.9K | 13 | N/A |
| New Hampshire | $1.5K | 15 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.